Quick Answer
Soy Isoflavones Bone Health Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits.
Key Takeaways
- 01Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits. [Shi Q (2026)]
- 02Objective : This study assessed dietary soy isoflavone (SIF) intake among Chinese women ≥14 years, identified determinants, and evaluated adequacy against the Specific Proposed Level (SPL) in Chinese Dietary Reference Intakes, to inform targeted guidance. [Shi Q (2026)]
- 03Methods : Intake was estimated using a distribution model combining 2017-2020 China National Food Consumption Survey data with SIF concentrations from food composition tables. [Shi Q (2026)]
The current Migaku evidence database contains 1 reusable source document for Soy Isoflavones Bone Health Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits. [Shi Q (2026); evidence level 3]
- Objective : This study assessed dietary soy isoflavone (SIF) intake among Chinese women ≥14 years, identified determinants, and evaluated adequacy against the Specific Proposed Level (SPL) in Chinese Dietary Reference Intakes, to inform targeted guidance. [Shi Q (2026); evidence level 3]
- Methods : Intake was estimated using a distribution model combining 2017-2020 China National Food Consumption Survey data with SIF concentrations from food composition tables. [Shi Q (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources